Exploratory analysis of the visceral disease subgroup in a phase III study of abiraterone acetate in metastatic castration-resistant prostate cancer

BACKGROUND: Visceral disease, non-nodal soft-tissue metastases predominantly involving the lung and liver, is a negative prognostic factor in patients with metastatic castration-resistant prostate cancer (mCRPC). An exploratory analysis of COU-AA-301 assessed whether abiraterone acetate (AA) improve...

Descripción completa

Detalles Bibliográficos
Autores principales: Goodman, O B, Flaig, T W, Molina, A, Mulders, P F A, Fizazi, K, Suttmann, H, Li, J, Kheoh, T, de Bono, J S, Scher, H I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921671/
https://www.ncbi.nlm.nih.gov/pubmed/24080993
http://dx.doi.org/10.1038/pcan.2013.41

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921671/
https://www.ncbi.nlm.nih.gov/pubmed/24080993
http://dx.doi.org/10.1038/pcan.2013.41

Ejemplares similares